Androgens added to immunosuppressive regimen in patients with aplastic anaemia. A retrospective study
Background: Androgens have been used to treat bone marrow failure syndromes such as aplastic anaemia (AA) since the 1970s, and are currently used as adjuvants to other treatment regimens. Objective: To determine the efficacy and response time of androgens in the treatment of AA. Materials and method...
Main Authors: | C.O. Ramos-Peñafiel, V.E. Ferrer-Argote, R. Trejo-Ayala, G. León-González, A. Santoyo-Sánchez, J. Collazo-Jaloma |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2015-07-01
|
Series: | Revista Médica del Hospital General de México |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0185106315000499 |
Similar Items
-
APLASTIC ANAEMIA – THERAPEUTIC AND DEONTOLOGICAL ASPECTS
by: Andreea Ligia Dinca, et al.
Published: (2016-03-01) -
Mapping aplastic anaemia hospital activity in England
by: Bamidele Famokunwa, et al.
Published: (2024-04-01) -
The Benign Clone Causing Aplastic Anaemia
by: Shaun R. McCann, et al.
Published: (2023-06-01) -
Neuroborreliosis in patient with aplastic anaemia secondary to therapy with ticlopidine
by: Čolović Milica, et al.
Published: (2010-01-01) -
Aplastic anaemia caused bythiamazole: A case report
by: Milošević Rajko, et al.
Published: (2004-01-01)